Selective antagonist of α3β2 nAChR receptors
CAT No: R1006
CAS No:705300-84-1
Synonyms/Alias:alpha-conotoxin PnIA;705300-84-1;A-CONOTOXIN PNIA;CHEMBL4443205;alpha-Conotoxin PnIA TFA;GTPL3982;BDBM50516319;AKOS024457442;DA-79161;Q27074398;S-705300-84-1;
α-Conotoxin PnIA is a synthetic peptide derived from the venom of the marine cone snail Conus pennaceus, recognized for its potent and selective modulation of neuronal nicotinic acetylcholine receptors (nAChRs). As a member of the α-conotoxin family, it is characterized by its defined disulfide-bridged structure and high specificity for particular nAChR subtypes, especially the α7 and α3β2 isoforms. This peptide has become an invaluable molecular tool in neuropharmacology and ion channel research, offering insight into the physiological roles of nAChRs in synaptic transmission and neuronal signaling. Its unique binding properties and selectivity underpin its broad utility in the study of ligand-gated ion channel mechanisms and receptor subtype pharmacology.
Neuroreceptor Characterization: α-Conotoxin PnIA is widely utilized in the functional characterization of neuronal nicotinic acetylcholine receptors. Its high affinity and selectivity for α7 and α3β2 nAChR subtypes enable researchers to dissect the contributions of these receptors to synaptic activity and neurotransmission. By selectively inhibiting specific receptor isoforms, the peptide assists in mapping the distribution, pharmacological profile, and physiological relevance of nAChR subtypes in various neural tissues.
Ion Channel Pharmacology: In the field of ion channel research, this conotoxin serves as a reference ligand for studying the structural and functional properties of ligand-gated ion channels. Its ability to distinguish between closely related nAChR subtypes makes it a valuable probe for elucidating the molecular determinants of receptor selectivity and channel gating. Investigations leveraging α-Conotoxin PnIA have advanced the understanding of allosteric modulation, ligand binding sites, and conformational changes associated with channel activation and inhibition.
Peptide Structure-Function Analysis: The defined disulfide framework and sequence motifs of α-Conotoxin PnIA make it a model system for peptide structure-function studies. Researchers employ this peptide to analyze the impact of amino acid substitutions, disulfide connectivity, and conformational constraints on biological activity and receptor interaction. Such studies inform the rational design of novel peptide analogs and contribute to broader efforts in peptide engineering and therapeutic lead discovery.
Neurotoxin Mechanism Exploration: As a naturally derived neurotoxin, α-Conotoxin PnIA provides a platform for investigating the mechanisms by which venom peptides modulate neuronal signaling. Its precise mode of action, involving competitive inhibition of acetylcholine binding, is studied to elucidate the broader principles of neurotoxin-receptor interactions. These insights are valuable for understanding the evolutionary adaptation of marine toxins and their potential as molecular tools in neuroscience.
Analytical and Detection Tool: The high specificity of α-Conotoxin PnIA for certain nAChR subtypes also supports its use as an analytical reagent in receptor detection assays. Its application in binding studies, receptor quantification, and affinity purification protocols enables the selective isolation and identification of nAChR populations from complex biological samples. This facilitates research into receptor expression patterns, post-translational modifications, and functional changes under various physiological and experimental conditions.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.